Perspectives on complement and phagocytic cell responses to nanoparticles: From fundamentals to adverse reactions
Journal of Controlled Release · 2023-04 · 356 · 115-129
DOI: 10.1016/j.jconrel.2023.02.022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2023-04. Verfasst von S Moein Moghimi und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Newcastle University, Newcastle upon Tyne NE1 7RU, UK; Translational and Clinical Research Institute, Faculty of Health and Medic…. Hauptthemen laut MEDLINE: Phagocytes, Nanoparticles. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
The complement system, professional phagocytes and other cells such as Natural killer cells and mast cells are among the important components of the innate arm of the immune system. These constituents provide an orchestrated array of defences and responses against tissue injury and foreign particles, including nanopharmaceuticals. While interception of nanopharmaceuticals by the immune system is beneficial for immunomodulation and treatment of phagocytic cell disorders, it is imperative to understand the multifaceted mechanisms by which nanopharmaceuticals interacts with the immune system and evaluate the subsequent balance of beneficial versus adverse reactions. An example of the latter is adverse infusion reactions to regulatory-approved nanopharmaceuticals seen in human subjects. Here, we discuss collective opinions and findings from our laboratories in mapping nanoparticle-mediated complement and leucocyte/macrophage responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Newcastle University, Newcastle upon Tyne NE1 7RU, UK; Translational and Clinical Research Institute, Faculty of Health and Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK; Co…
- School of Pharmacy, Newcastle University, Newcastle upon Tyne NE1 7RU, UK; Translational and Clinical Research Institute, Faculty of Health and Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
- Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, 2100 Copenhagen Ø, Denmark.
- School of Pharmacy, College of Science, University of Lincoln, Lincoln LN6 7TS, UK.
- Department of Biomedical Sciences, University of Padua, Padua 35121, Italy.
- S. M. Discovery Group Inc., Centennial, CO, USA; S. M. Discovery Group Ltd., Durham, UK.
Förderung
- NIAID NIH HHS
Zitieren
APA
Moghimi, S. M., Haroon, H. B., Yaghmur, A., Hunter, A. C., Papini, E., Farhangrazi, Z. S., Simberg, D., & Trohopoulos, P. N. (2023). Perspectives on complement and phagocytic cell responses to nanoparticles: From fundamentals to adverse reactions. Journal of Controlled Release, 356, 115-129. https://doi.org/10.1016/j.jconrel.2023.02.022
Vancouver
Moghimi SM, Haroon HB, Yaghmur A, Hunter AC, Papini E, Farhangrazi ZS, et al. Perspectives on complement and phagocytic cell responses to nanoparticles: From fundamentals to adverse reactions. Journal of Controlled Release. 2023;356:115-129. doi:10.1016/j.jconrel.2023.02.022
BibTeX
@article{Moghimi2023,
author = {Moghimi, S Moein and Haroon, Hajira B and Yaghmur, Anan and Hunter, A Christy and Papini, Emanuele and Farhangrazi, Z Shadi and Simberg, Dmitri and Trohopoulos, Panagiotis N},
title = {Perspectives on complement and phagocytic cell responses to nanoparticles: From fundamentals to adverse reactions},
journal = {Journal of Controlled Release},
year = {2023},
volume = {356},
pages = {115--129},
doi = {10.1016/j.jconrel.2023.02.022}
}
EUVIMED